Lumara

Discussion in 'TherRx' started by Anonymous, Jun 4, 2014 at 10:13 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What is with this new name? This is the best name we could come up with? Just drop the price of Makena and problem solved.
     

  2. Anonymous

    Anonymous Guest

    The name change is really working. My doctors are prescribing so much more than they were before. Brilliant idea.
     
  3. Anonymous

    Anonymous Guest

    You can put lipstick on a pig, but it’s still a pig. Until GD and the rest of his teet suckers are gone its all the same. sorry folks nothing her to see.

    Insider
     
  4. Anonymous

    Anonymous Guest

    So you are saying this company is a pig?
     
  5. Anonymous

    Anonymous Guest

    Yep and until upper management is gone it still smells like one too!!
     
  6. Anonymous

    Anonymous Guest

    Start with CD in HR what a joke
     
  7. Anonymous

    Anonymous Guest

    Investors are getting a little worried

    Insider
     
  8. Anonymous

    Anonymous Guest

    Ok thanks so much Mr. Insider. The only thing the investors are worried about is the multiple they want to get when they sell the company. Insider go back under your rock now.
     
  9. Anonymous

    Anonymous Guest

    That is in the works.

    Insider
     
  10. Anonymous

    Anonymous Guest

    Ok insider-if sale is in the works, when? Will stock/share be sold or entire company? Give some details so us little people can prepare! No cryptic half messages got it? By the way, if you know so much, why are Alere reps being hired?
     
  11. Anonymous

    Anonymous Guest

    oink, oink, oink
     
  12. Anonymous

    Anonymous Guest

    Insiders wouldn't be talking.
    Look who owns company: Private Equity with little healthcare experience, let alone Pharma.
    If sales can get ginned up to $150-$175 million, look for either IPO or flip to someone like Teva.
    Adding any developmental stage products unlikely, despite much tire kicking.
    Board will only allow product additions generating $$ with clear way to add to profits.

    Hey haters: Revenue is up. Payers are listening. The new greg knows what he's doing, and is adding some talent to the thin roster. Good things will happen for investors, for sure. And for execs. Employees? Well, not so much.
     
  13. Anonymous

    Anonymous Guest


    Who cares anymore. It's over and has been for good while. Wake us up with we are finally sold.
     
  14. Anonymous

    Anonymous Guest

    I guess pre born babies aren't a real concern for you.
    Good luck creep. Greg will be along to fire you soon.
     
  15. Anonymous

    Anonymous Guest

    no one cares and this place is already dead.
     
  16. Anonymous

    Anonymous Guest

    This place will be sold by the end of the year.
     
  17. Anonymous

    Anonymous Guest

    The goofy management couldn't even get the name change right. Lumara is too close to Luminal, and has the potential for screw-ups and possible resultant litigation (Remember that the drug is used on pregnant women, a class of patients that won't take kindly to screw-ups that could have been avoided by selecting a drug product name that was unique and different from any other drug product)

    And you guys say that we have a "new" Greg, and additional seasoned executives? Yet, they make a product name change that was not too smart (Makena to Lumara).... any seasoned marketing/sales or pharma executive would have considered prescribing mix-ups caused by similar name products.
     
  18. Anonymous

    Anonymous Guest

    That's the company's and not the product name.
     
  19. Anonymous

    Anonymous Guest

    Uh, you don't even know what you are talking about. There were no product name changes. Have a clue before posting idiot.
     
  20. Anonymous

    Anonymous Guest

    Does anyone really know what's going on here? I doubt it!